Where is New Phase located?

New Phase is headquartered in Petah Tikva, Israel. It is registered at 5, אודם, פתח תקווה, 4951788.0.

Who is the current CEO of New Phase?

Ofer Shalev of New Phase. They have also founded 1 company.

Which legal entities is New Phase associated with?

New Phase is associated with New Phase Ltd.

How many employees does New Phase have?

As of Aug 31, 2026, the latest employee count at New Phase is 28.

Where does New Phase rank among its competitors?

New Phase ranks 5th amongst 19 active competitors, of which 5 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was QV Bioelectronics, which secured $6.05M in Jan, 2026.

Who are the top competitors of New Phase?

New Phase's top competitors include Novocure, QV Bioelectronics and ChemoTech. Among them, QV Bioelectronics secured the most recent funding round in January, 2026.

New Phase - 2026 Company Profile, Team, Funding & Competitors

New Phase is a funded company based in Petah Tikva (Israel), founded in 2013 by Ofer Shalev. It operates as a Provider of nanoparticle based tumor-targeting molecules for cancer treatment. The company has 19 active competitors, including 5 funded and 2 that have exited. Its top competitors include companies like Novocure, QV Bioelectronics and ChemoTech.

Company Details

Provider of nanoparticle based tumor-targeting molecules for cancer treatment. It offers a technology called Sarah Technology which involves injecting glucose-linked Sarah molecules in the blood streams which gets attached to tumor cells. These are biocompatible nanoparticles with a core of superparamagnetic iron oxide that accumulate in malignant tissue via the EPR (Enhanced Permeability & Retention) effect. It also has an external system which generates an alternating magnetic field (AMF) to heat the nanoparticles causing hyperthermic damage to cancer cells while sparing normal tissue.

Website: newphase.co.il/
Email ID: *****@newphase.co.il
Registered Address: 5, אודם, פתח תקווה, 4951788.0

Key Metrics

Founded Year

2013

Location

Petah Tikva, Israel

Stage

Funding Raised

Investors

Real-Life Innovations

Ranked

5^th among 19 active competitors

Employee Count

28 as on Aug 31, 2026

Similar Companies

Novocure & 19 more

View New Phase's full profile

New Phase is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
New Phase Ltd CIN: 514957620 , Israel, Active	Aug 08, 2013	-	-	-

New Phase is a funded company. New Phase has 1 institutional investor.

View details of New Phase's funding rounds and investors

The founders of New Phase is Ofer Shalev. Ofer Shalev is the CEO of New Phase.

Here are the details of New Phase's key team members:

Ofer Shalev: Founder & CEO of New Phase.
Contact Info: 1 email address

View details of New Phase's Founder profiles and Board Members

New Phase's employee count trend

New Phase has 28 employees as of Aug 26. Here is New Phase's employee count trend over the years:

Uncover New Phase's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of New Phase include Novocure, QV Bioelectronics and ChemoTech. Here is the list of Top 10 competitors of New Phase, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novocure 2000, Haifa (Israel), Public	Developer of therapeutics to treat solid tumours	$10M	Johnson & Johnson Innovation – JJDC, Pfizer Venture Investments ... & 13 others	63/100
2nd	QV Bioelectronics 2019, Manchester (United Kingdom), Series A	Manufacturer of electrotherapy devices for treating brain tumors	$9.63M	SOSV, PXN Ventures & 18 others	53/100
3rd	ChemoTech 2015, Lund (Sweden), Public	Developer of electroporation devices for the treatment of cancer	-	EIC Fund, Europa	48/100
4th	Autem Therapeutics 2022, Hanover (United States), Series A	Developer of bioelectric technology-based device for cancer	$11.5M	Zentynel, Spectra Investments & 1 others	43/100
5th	New Phase 2013, Petah Tikva (Israel), Funding Raised	Provider of nanoparticle based tumor-targeting molecules for cancer treatment	-	Real-Life Innovations	31/100
6th	LifeBridge Innovations 2016, Orlando (United States), Series A	Developer of electric connection-based device to treat human tissues and cure tumor-related diseases	$3.38M	-	29/100
7th	Gradient Medical 2020, Raleigh (United States), Funding Raised	Developer of pulsed electric field therapies for tumors	-	America’s Seed Fund, HHS	24/100
8th	LaZure Scientific 2006, Issaquah (United States), Deadpooled	Low dose alternating current to heat and preferentially destroy tumour cells	$5.16M	-	22/100
9th	CancerCell 2018, Los Angeles (United States), Seed	Developer of personalized bioelectric cancer tumor eradication therapy	-	Leonhardt Ventures	22/100
10th	TheraBionic 2001, Ettlingen (Germany), Funding Raised	Developer of a device to identify tumor-specific modulation frequencies	-	HHS	22/100